Breakthrough Device Designation Granted to pTau 217 Blood Test for Alzheimer’s Detection
Spear Bio’s pTau 217 blood test, a less-invasive solution for early Alzheimer’s diagnosis, received an FDA Breakthrough Device Designation.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
